検索結果

e in dry-eye diagnosis. This distribution will be implemented by way of a partnership between Senju and Rexxam. Through this alliance, Senju and Rexxam will further contribute to people’s ‘health and ...

お知らせ | 千寿製薬株式会社

Novel Treatment of Dry Eye Disease through TRPV1 Inhibition（PDF） 2025年12月22日 Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Ey...

お知らせ | 千寿製薬株式会社

Novel Treatment of Dry Eye Disease through TRPV1 Inhibition（PDF） 2025年12月22日 Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Ey...

0008, occurs when central retinal artery occlusion leads to irreversible impairment of visual field and vision loss. Approximately 90% of patients suffer severe visual impairment, resulting in less th...

0008, occurs when central retinal artery occlusion leads to irreversible impairment of visual field and vision loss. Approximately 90% of patients suffer severe visual impairment, resulting in less th...